Monoclonal antibodies:: Development and clinical perspective

被引：0
|
作者：
Borchmann, P
Riethmüller, G
Engert, A
机构：
[1] Univ Cologne, Innere Med Klin 1, D-50924 Cologne, Germany
[2] Univ Munich, Inst Immunol, D-80539 Munich, Germany
来源：
INTERNIST | 2001年 / 42卷 / 06期
关键词：
D O I：
10.1007/s001080170123
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：803 / +
页数：9
相关论文
共 50 条
  • [1] Clinical Development and Regulatory Pathways of Monoclonal Antibodies in Japan
    Liao, Hua
    Li, Zhaoyang
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (02) : 173 - 183
  • [2] Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
    Melero, Ignacio
    Grimaldi, Antonio M.
    Perez-Gracia, Jose L.
    Ascierto, Paolo A.
    CLINICAL CANCER RESEARCH, 2013, 19 (05) : 997 - 1008
  • [3] Biosimilar monoclonal antibodies: preclinical and clinical development aspects
    Goncalves, J.
    Araujo, F.
    Cutolo, M.
    Fonseca, J. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 698 - 705
  • [4] Clinical Development and Regulatory Pathways of Monoclonal Antibodies in Japan
    Hua Liao
    Zhaoyang Li
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 173 - 183
  • [5] Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective
    Yanli Zhuang
    Di Chen
    Amarnath Sharma
    Zhenhua Xu
    The AAPS Journal, 20
  • [6] Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective
    Zhuang, Yanli
    Chen, Di
    Sharma, Amarnath
    Xu, Zhenhua
    AAPS JOURNAL, 2018, 20 (06):
  • [7] MONOCLONAL-ANTIBODIES IN THE MANAGEMENT OF OVARIAN-CANCER - A CLINICAL PERSPECTIVE
    RUBIN, SC
    CANCER, 1993, 71 (04) : 1602 - 1612
  • [8] Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
    Chiarella, Pieranna
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (02) : 258 - 267
  • [9] Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
    Sharma, Atul
    Khante, Shyam
    Mahadik, Kakasaheb R.
    Gaikwad, Vinod L.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 965 - 977
  • [10] Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview
    Atul Sharma
    Shyam Khante
    Kakasaheb R. Mahadik
    Vinod L. Gaikwad
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 965 - 977
12345